Labussiere et al. found that TERTp mutations may be associated with poorer outcome in high-grade gliomas, [16] however, Pekmezci et al. reported that TERT-mutants had significantly worse survival only in IDH-WT astrocytoma, which includes grades II and III [23]. Here, IDH2 is linked to central nervous system cancer.